SCHEMBL7306102

SCHEMBL7306102

COc1cc(C)cc(OC)c1C1=NC(N)C(=O)N(C)c2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 1/20 0.60
GABRD O14764 1/20 0.60
GABRA1 P14867 1/20 0.60
GABRB1 P18505 1/20 0.60
GABRG2 P18507 1/20 0.60
GABRB3 P28472 1/20 0.60
GABRA5 P31644 1/20 0.60
GABRA3 P34903 1/20 0.60
GABRA2 P47869 1/20 0.60
GABRB2 P47870 1/20 0.60
GABRA4 P48169 1/20 0.60
GABRE P78334 1/20 0.60
GABRA6 Q16445 1/20 0.60
GABRG1 Q8N1C3 1/20 0.60
GABRG3 Q99928 1/20 0.60
GABRQ Q9UN88 1/20 0.60
CCKBR P32239 14/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7304003 0.91 GABRP (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7304648 0.87 GABRP (0.56) GABRPGABRDGABRA1GABRB1GABRG2
Oxalic Acid SCHEMBL8631269 0.86 GABRP (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9866516 0.78 GABRP (0.82) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9866520 0.78 GABRP (0.82) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9866526 0.78 GABRP (0.82) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7312531 0.77 CCKBR (0.40) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3287899 0.77 GABRP (0.71) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7314462 0.76 GABRA1 (0.59) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7304401 0.76 CCKBR (0.45) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5798353-A Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them SANOFI (FR) 1998-08-25 US disclosed
US-5719143-A Polysubstituted 3-acylamino-5-phenyl-1, 4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them SANOFI (FR) 1998-02-17 US disclosed
EP-0667344-A1 3-acylamino-5-(polysubstituted phenyl)-1,4-benzodiazepin-2-ones useful as CCK-receptor agonists SANOFI (FR) 1995-08-16 EP disclosed